Omeza
Complete wound care, delivered simply.
Founded 2014 · $15.0M raised
- Founded
- 2014
- Business Model
- B2B
- Website
- omeza.com
- Total Funding
- $15.0M
- Last Round
- $8.5M Series AJul 2026
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds for this company. The full record is or through the API.
About
Omeza Holdings, Inc. is a U.S.-based ocean biotechnology company developing and commercializing marine-derived peptides and lipid products for wound care. Its lead product, OCM, is an FDA-cleared drug-device wound matrix derived from marine lipids and cold-water fish peptides that reduces inflammation, disrupts bacterial biofilm, and supports tissue regeneration. Omeza products are formulated and manufactured in the USA.
Summary
Omeza is a Biotech company, founded in 2014. It has raised $15.0M in total across 2 rounds, most recently a $8.5M Series A round in Jul 2026.
Funding History
Jul 2026
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/omeza"><img src="https://indexed.vc/api/badge/company/omeza" alt="Omeza on Indexed.vc" width="260" height="76" /></a>